Understanding kidney cancer that has spread to lymph nodes
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This research study looks at the biology of kidney cancer that has spread to lymph nodes)Skip and tests tumor tissue to find which drugs might work best. By studying the tumor's genes and proteins, doctors hope to find more personalized treatment options for people with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have kidney cancer (renal cell carcinoma) that has spread to nearby lymph nodes.
- Your main kidney tumor is 7 centimeters (about 2.8 inches) or larger.
- The tumor shows a special pattern called 'multinodular' when looked at after surgery.
- You are older than 18 years.
- You have not had targeted therapy or immunotherapy for kidney cancer before surgery.
- You do not have cancer that has spread to distant organs, and you have no other active cancer (except cured skin cancer or early cervical cancer).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for people with high-risk kidney cancer who are having their whole kidney removed. It compares surgery alone versus surgery plus removing lymph nodes from the tumor area to see if removing the nodes helps control the cancer better.
This trial compares standard systemic therapy (medication) alone versus systemic therapy plus targeted radiation to the cancer spots for people with kidney cancer that has spread to a limited number of places (up to 5 spots). It aims to see if adding radiation helps control the cancer better.
This study tests a new type of radiation therapy that targets kidney cancer cells. It is for people whose cancer has returned or spread after at least two prior treatments, and aims to see if it can shrink tumors and slow the disease.
This trial tests a new drug called 177Lu-TLX250, which delivers radiation directly to kidney cancer cells. It is for people with advanced clear cell renal cell carcinoma that has returned or not responded to at least 2 prior treatments.
This study looks at lymph nodes in people with known or suspected kidney cancer to learn more about the disease. It may help researchers understand how kidney cancer affects the lymph system.
This trial studies whether removing the kidney tumor with “deferred cytoreductive nephrectomy” (surgery at a later time) works best for people whose metastatic kidney cancer is already present. It compares a standard treatment approach using either immunotherapy (nivolumab/ipilimumab) or a targeted pill plus immunotherapy (TKI/IO), with planned surgery afterward.
Hear when a new Renal Cell Carcinoma (Kidney Cancer) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.